Bipolar Disorder

Bipolar disorder is a recurrent mood disorder defined by episodes of abnormally elevated, expansive, or irritable mood — mania or hypomania — alternating with episodes of depression. It is among the most heritable conditions in psychiatry, affects roughly 2–3% of the U.S. population over a lifetime, and remains one of the most underdiagnosed conditions in primary care. The average delay from first episode to correct diagnosis still runs close to a decade, in large part because patients seek help during depressive episodes and the hypomanic episodes are not recognized as illness.

The clinical and treatment implications of getting the diagnosis right are large. Antidepressants given without a mood stabilizer in undiagnosed bipolar disorder can trigger mania, induce mixed states, accelerate cycling, and worsen long-term outcomes. Mood stabilization, by contrast, prevents recurrence and reduces lifetime morbidity. This page covers how we recognize bipolar disorder, how we distinguish it from unipolar depression, the major treatment options, and where primary care fits alongside psychiatric specialty care.

Bipolar I, Bipolar II, and related conditions

• Bipolar I disorder requires at least one lifetime manic episode — seven or more days of euphoric or irritable mood with marked impairment, hospitalization, or psychotic features. Depressive episodes are common but not required for the diagnosis.
• Bipolar II disorder requires at least one lifetime hypomanic episode (four or more days, no marked impairment, no hospitalization, no psychosis) plus at least one major depressive episode. The depression is usually the dominant problem and the reason patients present.
• Cyclothymic disorder — two or more years of fluctuating subsyndromal hypomanic and depressive symptoms that don't meet full criteria for an episode.
• Substance-induced and medical bipolar-spectrum presentations — stimulants, corticosteroids, levothyroxine excess, and thyrotoxicosis can mimic mania and need to be ruled out before committing to the diagnosis.

What mania and hypomania actually look like

The textbook description — grandiosity, racing thoughts, decreased need for sleep, pressured speech, distractibility, increased goal-directed activity, and impulsive risk-taking — is accurate but understates how this looks in real life. Most patients describe hypomania as a period of unusual productivity, confidence, sociability, and reduced sleep need that they enjoyed at the time. It is rarely volunteered as a problem. Useful questions for screening include:

• "Has there ever been a period of at least four days when you felt unusually energetic and confident, with much less need for sleep than usual, and friends or family noticed you weren't yourself?"
• "Have you ever spent money, made decisions, or pursued projects during those periods that surprised people who know you well?"
• "During those periods, did your thoughts race or were you unusually distractible?"

The Mood Disorder Questionnaire (MDQ) is a useful self-report screening instrument and is positive when three of the following three conditions are met: at least seven mood-symptom items endorsed, several occurring during the same episode, and resulting in moderate-to-serious problems. Family corroboration substantially improves diagnostic accuracy — patients often have less insight into hypomanic periods than the people who live with them.

Depression in bipolar disorder vs. unipolar depression

The depressive episodes of bipolar disorder are clinically indistinguishable from unipolar major depression in any individual episode. Features that should raise suspicion of an underlying bipolar diathesis include:

• Onset of first depressive episode before age 25
• Multiple prior depressive episodes (three or more)
• Family history of bipolar disorder, completed suicide, or psychiatric hospitalization in a first-degree relative
• Atypical features — hypersomnia, hyperphagia, leaden paralysis, mood reactivity
• Psychotic features during a depressive episode
• Postpartum onset
• Antidepressant-induced agitation, irritability, or rapid mood elevation in the past

When two or more of these features are present, formal screening for past hypomania is essential before initiating an antidepressant.

Causes and contributing factors

Bipolar disorder is highly heritable — twin studies suggest 70–85% concordance — but no single gene predicts the illness. The likely model is many small-effect common variants combined with rare large-effect variants and environmental triggers. Sleep disruption, stimulant use, alcohol, and major life stressors can trigger episodes in susceptible individuals. Disrupted circadian function appears to be central, which is why the most effective non-pharmacologic intervention — interpersonal and social rhythm therapy — focuses specifically on regularizing sleep, wake, and activity timing.

Treatment

Acute mania

Severe mania — particularly with psychosis, agitation, or risk to self or others — is a psychiatric emergency that may require hospitalization. First-line pharmacotherapy is a mood stabilizer or second-generation antipsychotic, often used in combination during acute episodes:

• Lithium — the original mood stabilizer, the only agent with strong evidence for reducing suicide risk; effective for acute mania, prevention of recurrence, and management of bipolar depression; requires monitoring of serum levels, kidney function, and thyroid function.
• Divalproex / valproic acid — rapid onset for mania, useful in rapid cycling and mixed states; teratogenic, so contraindicated in pregnancy and avoided in women of childbearing potential without contraception planning.
• Second-generation antipsychotics — aripiprazole, quetiapine, risperidone, olanzapine, cariprazine, and lurasidone are all FDA-approved for various phases of bipolar disorder.
• Benzodiazepines — lorazepam or clonazepam used short-term for agitation and sleep restoration during an acute episode.

Bipolar depression

Bipolar depressive episodes are treated differently from unipolar depression. Antidepressant monotherapy is avoided. FDA-approved options include quetiapine, the olanzapine-fluoxetine combination, lurasidone, and cariprazine. Lamotrigine is particularly useful for prevention of depressive recurrence in bipolar II disorder. Lithium monotherapy is effective for some patients with bipolar depression.

Maintenance

The goal of maintenance treatment is prevention of recurrence. Most patients require lifelong therapy. The agent that worked in the acute phase is usually continued, sometimes with dose reduction. Decisions about adding, switching, or simplifying maintenance regimens are best made with a psychiatrist; primary care can provide ongoing prescribing and monitoring once the regimen is stable.

Psychotherapy and lifestyle

Three evidence-based therapies for bipolar disorder are:

• Cognitive behavioral therapy (CBT) for bipolar disorder — tailored to the recognition of early warning signs and management of depressive symptoms
• Family-focused therapy — particularly valuable after a first hospitalization or in young adults still living with family
• Interpersonal and social rhythm therapy (IPSRT) — focused on stabilizing sleep, wake, and social routines to prevent circadian dysregulation

Regular sleep, avoidance of alcohol and recreational stimulants, limited shift work where possible, and a low-stimulant approach to caffeine are practical lifestyle pieces. Comorbid medical conditions — particularly thyroid disease, obesity, type 2 diabetes, and cardiovascular disease — are common and require active management.

Suicide risk

Bipolar disorder carries one of the highest lifetime suicide risks of any psychiatric illness — on the order of 6–15%. The risk is highest during depressive and mixed episodes, in the months following hospital discharge, and in patients with comorbid substance use. Lithium has unique evidence for reducing suicide risk. Direct, repeated discussion of suicidal thoughts is part of routine bipolar care and does not "plant" the idea — the evidence is unambiguous that it improves outcomes. If you or someone you know is in crisis, the 988 Suicide and Crisis Lifeline is free, confidential, and available 24/7.

How primary care fits in

At Zimmer Medical Group we work as part of a broader care team. We screen for bipolar disorder in patients presenting with depression, particularly when early-onset or recurrent. Once a psychiatrist has stabilized a regimen, we can manage routine medication refills, lab monitoring (lithium levels, kidney function, thyroid function, lipids, A1c), preventive care, and the medical comorbidities that disproportionately affect this population. We coordinate referrals to psychiatry and to therapy and can help navigate insurance issues that often complicate access.

If you have questions about a diagnosis you've received, suspect bipolar disorder in yourself or a family member, or need a primary care partner alongside your psychiatric care, contact us or schedule an appointment.